Dr. Fedorenko at EBMT 2024 скачать в хорошем качестве

Dr. Fedorenko at EBMT 2024

50th Annual Meeting of the EBMT 14-17 April 2024 Glasgow, UK The Annual Meeting of the EBMT is attended by more than 5,500 participants, including physicians, nurses, data managers, statisticians, quality managers, cell therapists, paediatricians, pharmacists, psychologists, psychiatrists and psychoanalysts, transplant coordinators, lab scientists, trainees, patients. This important congress ensures and encourages dialogues and information exchange, education and scientific productivity. Scientific program presenter: MD PhD, Dr. Denis Fedorenko Member of European Society of Blood and Marrow Transplantation (EBMT) TOPICS: • Effects Of High Dose Immunosuppressive Therapy with Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis from Patient’s Perspctive: Long Term Quality Of Life Outcomes • Fludarabine and Cyclophosphamide as a Safe and Effective Lymphoablative Conditioning Regimen for Multiple Sclerosis (MS) • Clinical Outcomes of High Dose Immunosuppressive Therapy (HDIT) with Autologous Hematopoietic Stem Cell Transplantation (AHSCT) in Multiple Sclerosis (Patients: Long-Term Single Center Experience) HOW TO APPLY FOR HSCT: Complete our questionnaire, describing your previous treatment and current functional status, to define whether HSCT is a meaningful and safe treatment option for you. This online form must be accompanied by the report of last MRI (Please attach only report, no MRI images are required) Link to the application: https://hsct-russia.com/application-f... E-mail: [email protected] Facebook page:   / 4multiplesclerosis   Facebook group:   / 404629779644453   Instagram page:   / ahsct_russia   Twitter page:   / ahsct_russia   #multiplesclerosis #stemcelltreatment #stemcellresearch #ms #hsct